Healthcare delivery
road infrastructure but also alleviates the strain on transportation systems, making roads less congested and promoting smoother traffic flow within communities. The Best Kept Secret report also shows that
clinical homecare enhances pharmacovigilance. This is achieved through patient education, intervention, monitoring and robust reporting mechanisms. Speaking to patients at home allows specialist clinical trainers to take the time to educate patients on medication administration, potential side effects and the importance of reporting any unusual symptoms. This contributes to a proactive approach to pharmacovigilance in the UK, especially where medicines and devices are new to market.
A strategic roadmap for integration A strategic, multi-faceted approach is needed to realise the potential of clinical homecare. We are currently scratching the surface of potential. An estimated 6.8 million people in the UK are living with a condition that could be appropriate for clinical homecare. The opportunity is significant. So, how do we make this ambition a reality? The recent House of Lords inquiry into clinical homecare was challenging, but also welcome. It highlighted some of the ways in which the industry and processes around it should improve. Key to this was a need for greater transparency and collaboration between the clinical homecare industry, the NHS, pharmaceutical manufacturers and patients. These partnerships can facilitate knowledge sharing, innovation, and the development of best practices, ensuring that clinical homecare services are incorporated into patient pathways in a way that is safe and effective. The government has committed to the appointment of a senior responsible officer for clinical homecare. This is an extremely welcome step. The Best Kept Secret report highlights the need for this role to encompass governance, clinical delivery and operational oversight, pharmacy, procurement, contracting, and pricing. This new senior leadership must play a leading role in bringing the NHS, pharmaceutical manufacturers and clinical homecare providers together to increase openness and transparency.
Unlocking potential The value and potential of clinical homecare is significant. It helps people access healthcare in a place that best suits their needs, with further benefits to the NHS and society. As we look to the future, clinical homecare should not be viewed as an emergency option, but as an integral
6.8 million people in the UK are living with a condition that could be appropriate for clinical homecare. The opportunity is significant. So, how do we make this ambition a reality?
component of a holistic healthcare system. Achieving this vision requires concerted effort, strategic investment, and a commitment to collaboration and innovation. The clinical homecare industry is ready to lead this charge, working alongside the NHS, policymakers, patients and the wider healthcare community. Together, we can create a healthcare system that is not only responsive to the needs of
SCAN ME About the author
To read Best Kept Secret: The Value of Clinical Homecare to the NHS, Patients and Society visit:
www.clinicalhomecare.org/
bestkeptsecret or scan the QR code.
Chris Carver has 20 years’ experience in clinical homecare and is currently Deputy Chief Executive of HealthNet Homecare. He is also Treasurer of the NCHA. He graduated in Computer Science from Imperial College London and later competed a Master’s in Business Administration. During his career, Chris has held leadership roles in supermarket, automotive, and the pharmaceutical sectors. Chris’s interests include the use of digital tools and real-world data and evidence to improve patient access and health outcomes.
June 2024 I
www.clinicalservicesjournal.com 55
today’s population but also resilient and adaptable for future generations. The time for clinical homecare is now.
CSJ
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88
